Soft Tissue Sarcoma Epidemiology
In the year 2017, the total Soft tissue sarcoma incident population in the 7MM was observed to be approximately 40,155. The US accounted for the maximum number of soft tissue sarcoma incidence cases, followed by Germany.
The Key Soft tissue sarcoma companies working in the field including Eli Lilly and Company, Novartis, GSK, Bayer Pharmaceuticals, Blueprint Medicines, Advenchen Laboratories, LLC /Jiangsu Chia-Tai Tianqing Pharmaceutical, Karyopharm Therapeutics Inc., Deciphera Pharmaceuticals, Philogen S.p.A., Epizyme, Pfizer, AADi Bioscience, INC, and many others are developing novel therapies to treat soft tissue sarcoma.
To read more visit: https://www.delveinsight.com/blog/soft-tissue-sarcoma/
#pharmaceutical #biotechnology #healthcare #market #marketresearch #lifesciences #medical #health #sarcoma #softtissuesarcoma